Importantly, we also provide clinical evidence verifying the negative link between GSTZ1 and HIF-1α in tumors from patients with HCC, which helps us better understand the mechanisms by which GSTZ1 suppresses HCC progression and metastasis. This evidence concerns the gene GSTZ1 and hepatocellular carcinoma.